EPISODE · Jan 27, 2026 · 14 MIN
660. 基因编辑开启高胆固醇终身治疗新篇章
from 知为谁 · host 知为谁
这项初步临床试验研究了一种名为 CTX310 的新型 CRISPR 基因编辑药物，旨在通过一次性注射永久降低人体内的有害胆固醇和甘油三酯水平。研究结果显示，该疗法能让患者的脂肪指标减少约一半，为那些无法通过传统药物控制血脂的患者提供了潜在的终身解决方案。尽管早期实验证明了其初步有效性与安全性，但由于这种对肝脏基因的修改是不可逆的，医学专家对其长期副作用仍持有谨慎态度。目前该技术正处于早期阶段，未来还需要更大规模的实验来确保其在广泛应用前的安全性，以期最终降低心脏病这一全球头号死因的风险。内容来源：https://www.nbcnews.com/health/health-news/harmful-cholesterol-levels-cut-half-one-time-gene-editing-drug-early-t-rcna242320
Embed this episode
Ready to play
660. 基因编辑开启高胆固醇终身治疗新篇章
0:00
14:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 知为谁?
This episode is 14 minutes long.
When was this 知为谁 episode published?
This episode was published on January 27, 2026.
Can I download this 知为谁 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!